Bostanex (siro)

Bostanex (siro)

Bostanex (siro)

201912-0107 • 15816 Views • Box of 01 bottle x 30 ml. Box of 01 bottle x 60 ml
COMPOSITION

Each 1 ml of oral solution contains:

Active ingredient:

Desloratadine 0.5mg

 

BOSTANEX are indicated for the relief of symptoms associated with:

  Allergic rhinitis

  Urticaria

POSOLOGY AND METHOD OF ADMINISTRATION

Posology

Children 1 through 5 years of age: 2.5 ml Desloratadine oral solution once a day.

Children 6 through 11 years of age: 5 ml Desloratadine oral solution once a day.

Adults and adolescents (12 years of age and over): 10 ml Desloratadine oral solution once a day.

Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of the patient's disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance.

In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure periods

Administration

Oral use.

The dose can be taken with or without food.

 

CONTRAINDICATIONS

Hypersensitivity to desloratadine, loratadine, or any ingredient of drug.

 

WARNINGS AND PRECAUTIONS

In children below 2 years of age, the diagnosis of allergic rhinitis is particularly difficult to distinguish from other forms of rhinitis. The absence of upper respiratory tract infection or structural abnormalities, as well as patient history, physical examinations, and appropriate laboratory and skin tests, should be considered.

The safety of desloratadine in children 2-to 11-years of age who are poor metabolizers is the same as in children who are normal metabolizers.

The effects of desloratadine in poor metabolizers < 2 years of age have not been studied.

In the case of severe renal insufficiency, Desloratadine should be used with caution 

Desloratadine should be administered with caution in patients with medical or familial history of seizures, and mainly young children being more susceptible to developing new seizures under desloratadine treatment

This medicine contains sorbitol so patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

BOSTANEX contains:

- Yellow number 6: May cause allergic reactions.

- 0.824 mg sodium per 1 ml of the oral solution so be careful with the patients on a low sodium diet

- 667 mg sucrose per 1 ml of oral solution. This should be taken into account in patients with diabetes mellitus.

 

SHELF-LIFE

36 months from the manufacturing date. Do not use after the expiry date

 

Box of 01 bottle x 30 ml

Box of 01 bottle x 60 ml

Your comment

Similar products

PERIBOSTON
 Box of 10 blisters x 10 tablets.
Contact Us
CETIRIZIN BOSTON
Box of 10 blisters x 10 film-coated tablets
Contact Us
Soluboston 20 (effervescent tablets)
Box of 02 strips x 10 effervescent tablets.
Contact Us
Cetiboston
Box of 05 blisters x 10 soft capsules
Contact Us
Bostanex
Box of 03 blisters x 10 film-coated tablets
Contact Us
FexoBoston 60
Box of 3 blisters x 10 film-coated tablets
Contact Us
FexoBoston 180
Box of 3 blisters x 10 film-coated tablets
Contact Us
Benoboston
01 bottle x 500 tablets, Box of 10 blisters x 10 tablets
Contact Us
Clorpheboston
 Box of 01 bottle x 1000 film-coated tablets. Box of 01 bottle x 200 film-coated tablets.
Contact Us
Bostadin
Box of 10 blisters x 10 film-coated tablets
Contact Us
19001910